Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|September 19, 2022
Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patientsPatrizia Chiusolo, Elisabetta Metafuni, Gessica Minnella, et al.Leukemia|October 4, 2023
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational studyBruno Fattizzo, Carmelo Gurnari, Giulio Cassanello, et al.American Journal of Hematology|March 3, 2018
First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012Andrea Bacigalupo, Rosi Oneto, Hubert Schrezenmeier, et al.International Journal of Molecular Sciences|June 12, 2026
TP53 Mutations Unfavorably Impact the Outcomes of Myelofibrosis Patients with or Without Hematopoietic Stem Cell Transplantation: A Single-Center Study and Meta-AnalysisFilippo Frioni, Sabrina Giammarco, Sara Ceglie, et al.American Journal of Hematology|January 29, 2025
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real WorldBruno Fattizzo, Carmelo Gurnari, Sabrina Giammarco, et al.Bone Marrow Transplantation|December 17, 2020
Second haploidentical stem cell transplantation for primary graft failureSabrina Giammarco, Anna Maria Raiola, Carmen Di Grazia, et al.Frontiers in Oncology|July 17, 2024
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature reviewElisabetta Metafuni, Maria Teresa Busnego Barreto, Caterina Giovanna Valentini, et al.Frontiers in Medicine|February 8, 2024
Acute graft versus host disease 1976-2020: reduced incidence and predictive factorsAlessandra Di Francesco, Anna Maria Raiola, Alida Dominietto, et al.Blood Advances|December 17, 2021
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantationElisabetta Metafuni, Irene Maria Cavattoni, Teresa Lamparelli, et al.Frontiers in Oncology|December 19, 2022
Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experienceFrancesco Autore, Luca Stirparo, Idanna Innocenti, et al.Pageof 6